BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 21513347)

  • 1. Reagents for astatination of biomolecules. 5. Evaluation of hydrazone linkers in (211)At- and (125)I-labeled closo-decaborate(2-) conjugates of Fab' as a means of decreasing kidney retention.
    Wilbur DS; Chyan MK; Hamlin DK; Nguyen H; Vessella RL
    Bioconjug Chem; 2011 Jun; 22(6):1089-102. PubMed ID: 21513347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
    Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF
    Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reagents for astatination of biomolecules. 4. Comparison of maleimido-closo-decaborate(2-) and meta-[(211)At]astatobenzoate conjugates for labeling anti-CD45 antibodies with [(211)At]astatine.
    Wilbur DS; Thakar MS; Hamlin DK; Santos EB; Chyan MK; Nakamae H; Pagel JM; Press OW; Sandmaier BM
    Bioconjug Chem; 2009 Oct; 20(10):1983-91. PubMed ID: 19731929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reagents for astatination of biomolecules. 3. Comparison of closo-decaborate(2-) and closo-dodecaborate(2-) moieties as reactive groups for labeling with astatine-211.
    Wilbur DS; Chyan MK; Hamlin DK; Perry MA
    Bioconjug Chem; 2009 Mar; 20(3):591-602. PubMed ID: 19236022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reagents for astatination of biomolecules. 6. An intact antibody conjugated with a maleimido-closo-decaborate(2-) reagent via sulfhydryl groups had considerably higher kidney concentrations than the same antibody conjugated with an isothiocyanato-closo-decaborate(2-) reagent via lysine amines.
    Wilbur DS; Chyan MK; Nakamae H; Chen Y; Hamlin DK; Santos EB; Kornblit BT; Sandmaier BM
    Bioconjug Chem; 2012 Mar; 23(3):409-20. PubMed ID: 22296587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of radioiodinated protein conjugates and their potential metabolites containing lysine-urea-glutamate (LuG), PEG and closo-decaborate(2-) as models for targeting astatine-211 to metastatic prostate cancer.
    Li Y; Chyan MK; Hamlin DK; Nguyen H; Vessella R; Wilbur DS
    Nucl Med Biol; 2021 Jan; 92():217-227. PubMed ID: 32409263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody Fab' fragment cross-linking using equilibrium transfer alkylation reagents. A strategy for site-specific conjugation of diagnostic and therapeutic agents with F(ab')2 fragments.
    Wilbur DS; Stray JE; Hamlin DK; Curtis DK; Vessella RL
    Bioconjug Chem; 1994; 5(3):220-35. PubMed ID: 7918742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site specific discrete PEGylation of (124)I-labeled mCC49 Fab' fragments improves tumor MicroPET/CT imaging in mice.
    Ding H; Carlton MM; Povoski SP; Milum K; Kumar K; Kothandaraman S; Hinkle GH; Colcher D; Brody R; Davis PD; Pokora A; Phelps M; Martin EW; Tweedle MF
    Bioconjug Chem; 2013 Nov; 24(11):1945-54. PubMed ID: 24175669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and in vivo evaluation of radioiodinated closo-decaborate(2-) derivatives to identify structural components that provide low retention in tissues.
    Wilbur DS; Chyan MK; Hamlin DK; Perry MA
    Nucl Med Biol; 2010 Feb; 37(2):167-78. PubMed ID: 20152716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of cleavable and noncleavable hydrazinopyridine linkers for the 99mTc labeling of Fab' monoclonal antibody fragments.
    Bridger GJ; Abrams MJ; Padmanabhan S; Gaul F; Larsen S; Henson GW; Schwartz DA; Longley CB; Burton CA; Ultee ME
    Bioconjug Chem; 1996; 7(2):255-64. PubMed ID: 8983348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific conjugation of chain-terminal chelating polymers to Fab' fragments of anti-CEA mAb: effect of linkage type and polymer size on conjugate biodistribution in nude mice bearing human colorectal carcinoma.
    Slinkin MA; Curtet C; Sai-Maurel C; Gestin JF; Torchilin VP; Chatal JF
    Bioconjug Chem; 1992; 3(6):477-83. PubMed ID: 1463777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioiodinated iodobenzoyl conjugates of a monoclonal antibody Fab fragment. In vivo comparisons with chloramine-T-labeled Fab.
    Wilbur DS; Hadley SW; Grant LM; Hylarides MD
    Bioconjug Chem; 1991; 2(2):111-6. PubMed ID: 1868113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab' colocalization with recombinant streptavidin and avidin.
    Wilbur DS; Hamlin DK; Vessella RL; Stray JE; Buhler KR; Stayton PS; Klumb LA; Pathare PM; Weerawarna SA
    Bioconjug Chem; 1996; 7(6):689-702. PubMed ID: 8950488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetic characteristics of glycolated humanized anti-Tac Fabs are determined by their isoelectric points.
    Kobayashi H; Le N; Kim IS; Kim MK; Pie JE; Drumm D; Paik DS; Waldmann TA; Paik CH; Carrasquillo JA
    Cancer Res; 1999 Jan; 59(2):422-30. PubMed ID: 9927057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor.
    Burvenich IJ; Schoonooghe S; Blanckaert P; Bacher K; Vervoort L; Coene E; Mertens N; De Vos F; Slegers G
    Nucl Med Biol; 2007 Apr; 34(3):257-65. PubMed ID: 17383575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of anti-EGFR-Fab' conjugated immunoliposomes modified with two different conjugation linkers for siRNa delivery in SMMC-7721 cells.
    Deng L; Zhang Y; Ma L; Jing X; Ke X; Lian J; Zhao Q; Yan B; Zhang J; Yao J; Chen J
    Int J Nanomedicine; 2013; 8():3271-83. PubMed ID: 24023515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution of the chimeric monoclonal antibody U36 radioiodinated with a closo-dodecaborate-containing linker. Comparison with other radioiodination methods.
    Nestor M; Persson M; Cheng J; Tolmachev V; van Dongen G; Anniko M; Kairemo K
    Bioconjug Chem; 2003; 14(4):805-10. PubMed ID: 12862434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor targeting properties of indium-111 labeled genetically engineered Fab' and F(ab')2 constructs of chimeric tumor necrosis treatment (chTNT)-3 antibody.
    Khawli LA; Alauddin MM; Hu P; Epstein AL
    Cancer Biother Radiopharm; 2003 Dec; 18(6):931-40. PubMed ID: 14969605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of iodovinyl antibody conjugates: comparison with a p-iodobenzoyl conjugate and direct radioiodination.
    Hadley SW; Wilbur DS
    Bioconjug Chem; 1990; 1(2):154-61. PubMed ID: 2095212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.